首页> 外国专利> USE OF (S,S)-REBOXETINE IN THE TREATMENT OF PAIN CONDITIONS AND INCONTINENCE

USE OF (S,S)-REBOXETINE IN THE TREATMENT OF PAIN CONDITIONS AND INCONTINENCE

机译:(S,S)-瑞波西汀在治疗疼痛和无力状态中的用途

摘要

Methods and compositions for treating humans suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or a condition where inhibiting reuptake of norepinephrine is a benefit are disclosed. The compositions comprise a compound having a pharmacological selectivity of serotonin (Ki)/norepinephrine (Ki) of at least about 5000. Examples of such compounds include reboxetine, and more preferably optically pure (S,S) enantiomer of reboxetine. The methods generally include administration of a therapeutic amount of such compositions. Also disclosed are preparations of a medicament from the composition, and uses of the composition in a manufacture of the medicament to treat a human suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or condition.
机译:公开了用于治疗患有或预防人类的生理或精神疾病,病症或抑制去甲肾上腺素的再摄取是有益的病症的人的方法和组合物。该组合物包含具有5-羟色胺(Ki)/去甲肾上腺素(Ki)的药理学选择性为至少约5000的化合物。此类化合物的实例包括瑞波西汀,更优选为瑞波西汀的光学纯(S,S)对映异构体。该方法通常包括施用治疗量的此类组合物。还公开了由所述组合物制备药物,以及所述组合物在制备药物中的用途,所述药物用于治疗患有或预防患有生理或精神疾病,病症或病状的人。

著录项

  • 公开/公告号IL187513A

    专利类型

  • 公开/公告日2008-06-05

    原文格式PDF

  • 申请/专利权人 PHARMACIA & UPJOHN COMPANY LLC;

    申请/专利号IL187513

  • 发明设计人

    申请日2007-11-20

  • 分类号A61K45/00;A61Knull/null;A61K31/00;A61K31/5375;A61P1/14;A61P3/04;A61P11/00;A61P13/10;A61P25/00;A61P25/02;A61P25/06;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/32;A61P25/34;A61P25/36;A61P39/02;A61P43/00;

  • 国家 IL

  • 入库时间 2022-08-21 20:07:57

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号